Report period | 2019 | 2020 | 2021 | 2022 | Q2 23 |
---|---|---|---|---|---|
End date of the reporting period | |||||
Capitalization, $ | |||||
Capitalization, $ | |||||
Enterprise Value | |||||
Book Value | |||||
Shareholders Book Value | |||||
Current liabilities | |||||
Noncurrent liabilities | |||||
Total liabilities | |||||
Debt | |||||
Cash and cash equivalents | |||||
Net debt | |||||
Assets | |||||
Total ordinary shares | |||||
Ordinary share price |
Company name | Vaccitech |
---|---|
Tags | #biotechnology, #cancer treatment |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
Business address | The Schrodinger Building, 2nd Floor Heatley Road The Oxford Science Park Oxford OX4 4GE United Kingdom |
Mailing address | The Schrodinger Building, 2nd Floor Heatley Road The Oxford Science Park Oxford OX4 4GE United Kingdom |
Website | investors.vaccitech.co.uk |